These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3261799)

  • 1. Synthesis, conformation, and immunosuppressive activity of a conformationally restricted cyclosporine lactam analogue.
    Aebi JD; Guillaume D; Dunlap BE; Rich DH
    J Med Chem; 1988 Sep; 31(9):1805-15. PubMed ID: 3261799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and immunosuppressive activities of conformationally restricted cyclosporin lactam analogues.
    Lee JP; Dunlap B; Rich DH
    Int J Pept Protein Res; 1990 May; 35(5):481-94. PubMed ID: 2376472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, conformation, and immunosuppressive activity of cyclosporines that contain epsilon-oxygen (4R)-4-[(E)-butenyl]-4,N-dimethyl-L-threonine analogues in the 1-position.
    Sun CQ; Guillaume D; Dunlap B; Rich DH
    J Med Chem; 1990 May; 33(5):1443-52. PubMed ID: 2329566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin analogs modified in the 3,7,8-positions: substituent effects on peptidylprolyl isomerase inhibition and immunosuppressive activity are nonadditive.
    Hu MK; Badger A; Rich DH
    J Med Chem; 1995 Oct; 38(21):4164-70. PubMed ID: 7473543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological activity, and conformational analysis of (2S,3R,4S)-MeBmt1-cyclosporin, a novel 1-position epimer of cyclosporin A.
    Rich DH; Sun CQ; Guillaume D; Dunlap B; Evans DA; Weber AE
    J Med Chem; 1989 Aug; 32(8):1982-7. PubMed ID: 2754718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antimitogenic activities of four analogues of cyclosporin A modified in the 1-position.
    Rich DH; Dhaon MK; Dunlap B; Miller SP
    J Med Chem; 1986 Jun; 29(6):978-84. PubMed ID: 3712387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, conformation, and immunosuppressive activities of three analogues of cyclosporin A modified in the 1-position.
    Aebi JD; Deyo DT; Sun CQ; Guillaume D; Dunlap B; Rich DH
    J Med Chem; 1990 Mar; 33(3):999-1009. PubMed ID: 2308150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the dependence of molecular conformation on the type of solvent environment: a molecular dynamics study of cyclosporin A.
    Lautz J; Kessler H; van Gunsteren WF; Weber HP; Wenger RM
    Biopolymers; 1990; 29(12-13):1669-87. PubMed ID: 2386812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and conformation of constrained peptides with hypoglycaemic activity derived from human growth hormone.
    Ede NJ; Rae ID; Hearn MT
    Int J Pept Protein Res; 1994 Dec; 44(6):568-81. PubMed ID: 7705979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimicry of beta II'-turns of proteins in cyclic pentapeptides with one and without D-amino acids.
    Weisshoff H; Präsang C; Henklein P; Frömmel C; Zschunke A; Mügge C
    Eur J Biochem; 1999 Feb; 259(3):776-88. PubMed ID: 10092864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation of MeAla6-cyclosporin A by NMR. Relationship of sidechain orientation of the MeBmt-1, MeLeu-9, and MeLeu-10 residues to immunosuppressive activity.
    Gooley PR; Durette PL; Boger J; Armitage IM
    Int J Pept Protein Res; 1991 May; 37(5):351-63. PubMed ID: 1917291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of cyclosporin A and a nonimmunosuppressive analog bound to fully deuterated cyclophilin.
    Hsu VL; Armitage IM
    Biochemistry; 1992 Dec; 31(51):12778-84. PubMed ID: 1463748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of N-terminal residue stereochemistry on the prolyl amide geometry and the conformation of 5-tert-butylproline type VI beta-turn mimics.
    Halab L; Lubell WD
    J Pept Sci; 2001 Feb; 7(2):92-104. PubMed ID: 11277501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary structure of cyclosporine in a spray-dried liquid crystal by FTIR.
    Stevenson CL; Tan MM; Lechuga-Ballesteros D
    J Pharm Sci; 2003 Sep; 92(9):1832-43. PubMed ID: 12950001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pseudo-beta I-turn. A new structural motif with a cis peptide bond in cyclic hexapeptides.
    Kessler H; Matter H; Gemmecker G; Diehl HJ; Isernia C; Mronga S
    Int J Pept Protein Res; 1994 Jan; 43(1):47-61. PubMed ID: 8138351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?
    Sigal NH; Dumont F; Durette P; Siekierka JJ; Peterson L; Rich DH; Dunlap BE; Staruch MJ; Melino MR; Koprak SL
    J Exp Med; 1991 Mar; 173(3):619-28. PubMed ID: 1997649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational mimicry: synthesis and solution conformation of a cyclic somatostatin hexapeptide containing a tetrazole cis amide bond surrogate.
    Beusen DD; Zabrocki J; Slomczynska U; Head RD; Kao JL; Marshall GR
    Biopolymers; 1995 Aug; 36(2):181-200. PubMed ID: 7492745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing D-amino acids for peptide motif designs. Synthesis and solution conformation of Boc-D-Glu-Ala-Gly-Lys-NHMe and Boc-L-Glu-Ala-Gly-Lys-NHMe.
    Bobde V; Sasidhar YU; Durani S
    Int J Pept Protein Res; 1994 Mar; 43(3):209-18. PubMed ID: 8005743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.
    Furue M; Katz SI
    J Immunol; 1988 Jun; 140(12):4139-43. PubMed ID: 3259608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analyses of sandostatin analogs containing stereochemical changes in positions 6 or 8.
    Mattern RH; Zhang L; Rueter JK; Goodman M
    Biopolymers; 2000 May; 53(6):506-22. PubMed ID: 10775066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.